Beximco Pharms USA's Generic Eletriptan Hydrobromide Receives Approval In US
Yung Shin Pharma`s Generic Eletriptan Hydrobromide Receives Approval in US
Enforcement Report - Week of September 4, 2019
Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets
The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling out a similar initiative, only with some extra incentives.
Enforcement Report - Week of May 22, 2019
Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare®
Aurobindo Pharma's Generic Eletriptan Hydrobromide Receives Approval in US
Ajanta Pharma’s Generic Eletriptan Hydrobromide Receives Approval In US
Teva Pharm’s Generic Eletriptan Hydrobromide Receives Approval In US